Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXDJ4K
|
||||
Drug Name |
2'-Methyl-4'-(5-methyl-[1,2,4]oxadiazol-3-yl)-biphenyl-4-carboxylic acid [4-(2-fluoro-ethoxy)-3-(4-methyl-piperazin-1-yl)-phenyl]-amide
|
||||
Synonyms |
CHEMBL151420
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C30H32FN5O3
|
||||
Canonical SMILES |
CN1CCN(CC1)c2cc(NC(=O)c3ccc(cc3)c4ccc(cc4C)c5noc(C)n5)ccc2OCCF
|
||||
InChI |
InChI=1S/C30H32FN5O3/c1-20-18-24(29-32-21(2)39-34-29)8-10-26(20)22-4-6-23(7-5-22)30(37)33-25-9-11-28(38-17-12-31)27(19-25)36-15-13-35(3)14-16-36/h4-11,18-19H,12-17H2,1-3H3,(H,33,37)
|
||||
InChIKey |
DUMFBDNWYSCVRA-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 1B receptor | Target Info | [1587926] | ||
Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
5HT2 type receptor mediated signaling pathway | |||||
5HT3 type receptor mediated signaling pathway | |||||
5HT4 type receptor mediated signaling pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.